Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical.

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

The role of cystatin C as a biomarker for prognosis in pulmonary arterial hypertension due to congenital heart disease Ilja M. Blok, Annelieke C.M.J. van.

Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population Sharmini Selvarajah, Gurpreet.

Volume 4, Pages (September 2014)

Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients.

Remko Kockelkoren, Pushpa M Jairam, John T. Murchison, Thomas P. A

M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M

Remy H. H. Bemelmans, Blai Coll, Daniel R

Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin Shirley.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Prostate Cancer Epidemic in Sight?

Prediction rule for cardiovascular events and mortality in peripheral arterial disease patients: Data from the prospective Second Manifestations of ARTerial.

Management of hypertension in patients with chronic kidney disease

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both Nadia Aissaoui, Edith Martins,

Prostate Cancer Epidemic in Sight?

M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M

Trends in comorbidity in patients hospitalised for cardiovascular disease Josefien Buddeke, Michiel L. Bots, Ineke van Dis, Anho Liem, Frank L.J. Visseren,

Epidemiology of ruptured abdominal aortic aneurysms in a well-defined Norwegian population with trends in incidence, intervention rate, and mortality

Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes Tim Luijkx, Birgitta K. Velthuis,

Tim J. van Oostenbrugge, MD, Jean-Paul P. M

Boudewijn L. Reichmann, MD, Jorinde H. H. van Laanen, MD, Jean-Paul P

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

International Journal of Cardiology

Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines.

Heart failure and inflammation-related biomarkers as predictors of new-onset diabetes in the general population Navin Suthahar, Wouter C. Meijers, Frank.

Kirolos A. Jacob, Marc P. Buijsrogge, Jos F. Frencken, Maarten J

Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls Vincent L. Aengevaeren, Maria T.E. Hopman,

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

2014 Global geographic analysis of mortality from ischaemic heart disease by country, age and income: Statistics from World Health Organisation and United.

Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review B.A. de Waal, M.P. Buise, A.A.J. van.

International Journal of Cardiology

Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population Sharmini Selvarajah, Gurpreet.

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

Support Your Specialty

Bouwe P. Krijthe, Maarten J. G. Leening, Jan Heeringa, Jan A

International Journal of Cardiology

Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase Carine I. van Capelle, Esther.

Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations Willem J. Verberk, Stefano.

International Journal of Cardiology

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Anne L. M. Vlek, MD, Yolanda van der Graaf, MD, PhD, Maayke A

International Journal of Cardiology

Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression Corline Brouwers, Stefan.

Age-dependent care and long-term (20year) mortality of 14,434 myocardial infarction patients: Changes from 1985 to 2008 Sjoerd T. Nauta, Jaap W. Deckers,

Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department J.M. Poldervaart,

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.

Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced.

Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008 Sanne M. Snelder, Sjoerd T. Nauta,

Trends in mortality risks among 94,328 patients surviving 30days after a first isolated coronary artery bypass graft procedure from 1987 to 2006: A population-based.

Table of contents The Journal for Nurse Practitioners

International Journal of Cardiology

Reviewer Acknowledgment

International Journal of Cardiology

International Journal of Cardiology

Koen W. Streng, Jan F. Nauta, Hans L. Hillege, Stefan D. Anker, John G

Perioperative hospital mortality at a tertiary paediatric institution

Discussion The Journal of Thoracic and Cardiovascular Surgery

FT04. “The Vein Is Screwed” Proof of Concept of the VeinScrew: A New Percutaneous Venous Closure Device Doeke Boersma, MD, Frans Moll, MD, PhD, Gert Jan.

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

News & Notes Journal of Allergy and Clinical Immunology

International Journal of Cardiology

International Journal of Cardiology

Borderline Q-waves in individuals without overt cardiovascular disease: Relations with adiposity, subclinical atherosclerosis and vascular stiffness

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

Presentation transcript:

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis Gijs F.N. Berkelmans, Yolanda van der Graaf, Jannick A.N. Dorresteijn, Gert Jan de Borst, Maarten J. Cramer, L. Jaap Kappelle, Jan Westerink, Frank L.J. Visseren International Journal of Cardiology Volume 251, Pages 96-102 (January 2018) DOI: 10.1016/j.ijcard.2017.07.026 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Trends in risk factors (A, B, C and D), risk factor management (E) and subclinical atherosclerotic burden (F) at baseline. International Journal of Cardiology 2018 251, 96-102DOI: (10.1016/j.ijcard.2017.07.026) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Crude incidence rates of recurrent major cardiovascular events. International Journal of Cardiology 2018 251, 96-102DOI: (10.1016/j.ijcard.2017.07.026) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Rate ratios of recurrent major cardiovascular events and all-cause mortality in the period 1996–2014. International Journal of Cardiology 2018 251, 96-102DOI: (10.1016/j.ijcard.2017.07.026) Copyright © 2017 The Authors Terms and Conditions